Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)

Clinical trial NCT04328961 · COMPLETED

Trial details

NCT number: NCT04328961
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

COVID-19 Corona Virus Infection SARS (Severe Acute Respiratory Syndrome)SARS-CoV-2

Start date: 2020-03-31
Primary completion: 2020-09-24
Enrollment: 943

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.